These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9400489)

  • 1. Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma.
    Kinoshita H; Ogawa O; Mitsumori K; Kakehi Y; Terachi T; Yoshida O
    J Urol; 1998 Jan; 159(1):245-51. PubMed ID: 9400489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity in renal cell carcinoma by modified telomeric repeat amplification protocol assay.
    Segawa N; Gohji K; Azuma H; Iwamoto Y; Ohnishi K; Katsuoka Y
    Int J Urol; 2003 Mar; 10(3):153-9. PubMed ID: 12622712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
    Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
    Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in human renal cell carcinoma.
    Fujioka T; Hasegawa M; Suzuki Y; Suzuki T; Sugimura J; Tanji S; Koike H
    Int J Urol; 2000 Jan; 7(1):16-21. PubMed ID: 10701886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in human renal cell carcinoma.
    Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
    Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity in renal cell carcinoma.
    Yoshida K; Sakamoto S; Sumi S; Higashi Y; Kitahara S
    Cancer; 1998 Aug; 83(4):760-6. PubMed ID: 9708942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity in human renal cell carcinoma.
    Sugimura K; Yoshida N; Hisatomi H; Nakatani T; Ikemoto S
    BJU Int; 1999 Apr; 83(6):693-7. PubMed ID: 10233581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma.
    Kanaya T; Kyo S; Takakura M; Ito H; Namiki M; Inoue M
    Int J Cancer; 1998 Nov; 78(5):539-43. PubMed ID: 9808519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma.
    Hara T; Noma T; Yamashiro Y; Naito K; Nakazawa A
    Urol Res; 2001 Feb; 29(1):1-6. PubMed ID: 11310208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity in human urothelial tumors.
    Kyo S; Kunimi K; Uchibayashi T; Namiki M; Inoue M
    Am J Clin Pathol; 1997 May; 107(5):555-60. PubMed ID: 9128268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
    Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
    Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity in malignant and benign renal tumors.
    Müller M; Heicappell R; Krause H; Sachsinger J; Porsche C; Miller K
    Eur Urol; 1999; 35(3):249-55. PubMed ID: 10072629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of telomere and telomerase in human primary gastric carcinoma].
    Zhang F; Zhang X; Fan D
    Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):429-32. PubMed ID: 11244953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer.
    Zhang DK; Ngan HY; Cheng RY; Cheung AN; Liu SS; Tsao SW
    Eur J Cancer; 1999 Jan; 35(1):154-60. PubMed ID: 10211104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity and telomere lengths: alterations in renal cell carcinomas.
    Dahse R; Fiedler W; Junker K; Schlichter A; Schubert J; Claussen U
    Kidney Int; 1999 Oct; 56(4):1289-90. PubMed ID: 10504477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast.
    Rha SY; Park KH; Kim TS; Yoo NC; Yang WI; Roh JK; Min JS; Lee KS; Kim BS; Choi JH; Lim HY; Chung HC
    Int J Oncol; 1999 Oct; 15(4):839-45. PubMed ID: 10493971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma.
    Lin F; Zhang PL; Yang XJ; Shi J; Blasick T; Han WK; Wang HL; Shen SS; Teh BT; Bonventre JV
    Am J Surg Pathol; 2007 Mar; 31(3):371-81. PubMed ID: 17325478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
    Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
    Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.